‘Viread’ positioned the top among imported products while anticancer and vaccines in top ranking
The reputation of hepatitis B treatments was still solid.
This is because ‘Viread(sold by Gilead and Yuhan Corporation)’ and ‘Baraclude(sold by BMS Korea, and sold by Green Cross from September last year)’ took the 1st and 2nd respectively in the imported drugs in Korea last year.
Moreover, t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
